Abstract -This article considers the gene ranking algorithm for the microarray data. The rank vector is estimated by classifications of the random data samples. At each iteration, the ranks of genes participating in the successful classification become higher. Unlike other methods of feature selection, the proposed algorithm allows increasing the generality of the classification models by construction of the balanced training samples and taking into account the descriptiveness of the gene combinations by the subset estimation.
I. INTRODUCTION
The improvement of the cancer diagnostics is one of the topmost aims in medicine. The defined diagnosis is the basis for the selection of the treatment protocol in order to simultaneously maximize the treatment efficiency and minimize the toxicity. Recently, the great attention is paid to the investigation of the potential of the cancer cell genetic information for adjustment of existing cancer subtypes and discovery of the new cancer subtypes at the molecular level. The results will aid in more accurate discrimination of cancer and will assist in more effective therapy.
Microarray technology presents the new era of biotechnologies and allows measuring the expression of thousands of genes simultaneously. Microarray data give the rich material for the deep understanding of differences between tumour subtypes at the molecular level and thereafter their more reliable classification. Microarray data are used both to determine up-regulated and down-regulated genes relative to the cancer subtypes under investigation and to identify gene signatures or biomarkers for the clinical diagnostics and prognosis [1] [2] .
Unfortunately, the information extraction from such kind of data is hampered by the strong imbalance between the number of samples (usually less than hundred) and the number of genes (usually tens of thousands). This discrepancy as a rule leads to overfitting, namely, the construction of the classification model with poor generality (low accuracy on independent set of data) [3] . Moreover, the microarray data enclose as a rule the measurement and systematic errors, which can considerably influence the classification accuracy. Therefore, the classification process as well as clustering must be preceded by the feature space preprocessing, which in our context means the process of feature (gene) selection by their ranking or feature reduction [4] .
The methods of feature selection for the tasks of cancer diagnostics as well as for all classification tasks are divided into two major groups: filter and wrapper methods [5] . Filter methods allow for the deletion of the uninformative features according to general data characteristics. They are computationally simpler and are not connected to a particular classification algorithm. The wrapper methods imply the use of the classification algorithm in the process of feature subset selection, which simultaneously improves the classification accuracy. The limitation of the wrapper methods is the high computational complexity, caused by the repeated application of classification algorithm during the selection process. For the informative gene subset selection, both the filter methods, e.g., standard parametric tests (t-test [6] ) or nonparametric tests (Wilcoxon signed-rank test [7] ) and the wrapper methods [8] [9] are used in the literature.
However, very often the subsets of the selected genes are greatly differentiated by different researchers that can be the result of both the discrepancy of analysed data dimensions and the ignoring of gene dependencies. To date, there are not unique recommendations on the methods of informative gene selection that are more adequate for a particular dataset [10] . The algorithm of gene selection proposed in our research allows overcoming the shortages of both the filter and wrapper approaches and is based on gene ranking by classification of repeated random samples from the initial dataset. The algorithm possesses the following advantages: it avoids the overfitting through forming the low-dimensional training matrices with predominance of sample number to the number of genes; it takes into account the informativity of gene combinations through feature subset estimation by a classification algorithm.
The paper presents the results of testing the algorithm on the leukaemia dataset, verification of the biological significance of the twenty top-ranked genes and a comparative analysis with similar studies of other authors.
II. ALGORITHM DESCRIPTION
Let M N X  be the initial matrix of gene expression, where M is the number of genes, N is the number of samples or data objects. 1 2 ( , , , ), 1,
is a vector of gene values for N samples or gene profile. Each data object is marked by the class label and in our research belongs to one of two classes. The algorithm can be automatically extended on datasets with more than two classes. Let us denote , 1 ,2 i N i  as the number of data objects of i th class, then 1 2 N N N   .
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The algorithm performs the feature ranking by classification of repeated random samples from initial gene expression matrix M N X  . To form the sample, the process of two-way bootstrapping is applied, namely m M  genes and n N  data objects are selected simultaneously from the initial matrix. The number of selected objects is defined by the parameter  , the number of genes is such that / 2 m n  . Two-way bootstrapping scheme gives the possibility at each iteration k to form balanced matrix k m n Y  , which according to research in [3] is less probable to overtraining. The number of iterations K is defined such that each gene in the dataset is selected the number of times sufficient to assess its rank. In addition to the number of iteration, the value of correlation between the rank vectors at the current and preceding iteration steps is used as another stopping criterion.
At each following step of iteration process, i.e., after the predefined number of iterations iter k the output matrix 
As a result, the training set of n data objects and the testing set of N n  data objects are formed. 2. Training matrix k m n Y  is classified using the nearest shrunken centroid method [11] . The cross-validation procedure is applied to search for the optimal classifier with minimal classification error on the training sample
Cross-validation allows defining the threshold value k  , which corresponds to the lowest classification error, achieved with the fewest number of genes in the subset 1 2 , , , l x x x  , where l m  . The resultant classification model 1 2 ( , , , )
is subsequently verified on the test set with N n  data objects. The classification error e is calculated as in (1) .
where FP -type I error, FN -type II error. When the minimal classifier error on the training set for all possible threshold values k  and gene subsets 1 2 , , , l x x x  , l m  exceeds the value  , then the verification on the testing set is bypassed and the execution proceeds to step 4.
3. If the classification error on the test set k e   , i.e., less than a predefined threshold the classification model is assumed as successful and the output matrix 
P are sequentially modified as follows: are modified as follows:
If the classification error on the test set
The rank values are defined by sorting the gene prognostic values , 1 , 
, is estimated using the Spearman rank correlation coefficient like in (4).
The algorithm stops if the correlation coefficient r   (e.g., 0.99   ), i.e., the rank vector is stabilized.
III. DATASETS AND EXPERIMENTS
In our research we used the real Leukaemia dataset [12] to test the proposed gene ranking algorithm and to conduct the comparative analysis of the results. The Leukaemia dataset includes the bone marrow samples obtained from acute leukaemia patients at the time of diagnosis: 25 acute myeloid leukaemia (AML) samples and 47 acute lymphoblastic leukaemia (ALL) (24 acute 9 T-lineage acute lymphoblastic leukaemia samples; and 38 B-lineage ALL samples), characterized by expression of 7129 genes. According to the protocol in [13] the preprocessing steps include: 1) thresholding with minimal expression value of 100 and maximal expression value of 1600;
2) filtering the genes according to one of the conditions: max/ min 5  or (max min) 500   , where max -a maximum expression value and min -a minimum expression value;
3) logarithm transformation of gene values. After preprocessing, 3571 genes were selected. The dataset can be downloaded from the website [14] .
For the experiment the following parameters were selected: the number of iterations 300000 K  , the threshold value of the classification error 0.2
 
, the fraction of samples randomly selected from the initial dataset at each iteration 0.7
 
, the number of iterations iter k =20000 between the estimations of the stopping condition using the correlation coefficient with a threshold value 0.09 r  . After each iter k iteration, the output matrix 4 M E  was updated. Twenty topranked genes, received as a result of the experiment, are presented in Table I . The classification models were constructed for each of the twenty gene subsets for the whole dataset, starting from the one-element subset, which consists of one top-ranked gene (see Table I ), and then by adding the genes successively from the ranking list to form subsequent subsets. The classification errors were estimated and the gene subset with the minimal classification error was selected as the most informative one, which could be considered the potential disease biomarkers. Figure 1 shows the point graph of dependence of the classification error on the number of the selected genes, taken in the range from one to twenty.
According to error values (see Fig. 1 ) received using crossvalidation procedure on the whole dataset, the four genes can be selected as the biomarkers (Cd33, Zyxin, APLP2, CST3). The accuracy of the classifier using only four genes equals 98.6%. As shown in Fig. 1 , the set of ten genes gives a lower classification error, but requires the expression assessment of greater number of genes. The comparative analysis of the results of the proposed algorithm has shown its efficiency in recognizing the most informative genes, which are also present in the gene lists in [15] [16] [17] [18] . In addition, the proposed algorithm reaches the comparative classification accuracy (using the cross-validation procedure) using a smaller number of genes (Table II) . 
IV. BIOLOGICAL SIGNIFICANCE OF THE SELECTED GENES
In order to assess the biological significance of the results, the ranked gene subset consisting of twenty most informative genes was analysed using a web knowledge resource for innate immunity interactions and pathways InnateDB (http://www.innatedb.ca).
The potential functional interconnection of the gene subset with the disease phenotype and the biological pathways were revealed. The pathway overrepresentation analysis allowed defining the pathways that were significantly presented in the selected gene subset. The significance of the gene participation in the particular biological process was estimated by the p-value. According to the analysis, two (adipsin CFD and complement factor properdin CFP) out of the twenty genes take part in the alternative complement pathway, infectious agent suppression (p-level = 0.00006). In [18] , adipsin was also selected as a biomarker of the leukaemia subtype, its role in the myeloid cell differentiation was described.
Two out of 20 genes (CD33 and DNTT) are of the hematopoietic cell lineage (p-level = 0.00429). CD33 is a transmembrane receptor expressed on cells of myeloid lineage and is usually considered myeloid-specific, but it can also be found on some lymphoid cells [19] . DNTT (deoxynucleotidyltransferase) is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation.
Two genes of the subset (cyclin D3 и CD79A) are the members of the B Cell receptor signalling and cell cycle pathways (p-level = 0.01489). The cyclin D3 gene together with zyxin takes part in the process of Focal adhesion (plevel = 0.0225). In [20] , zyxin was selected as a biomarker of the leukaemia phenotypes. The expression level of zyxin is important for the leukaemia subtype differentiation, but its role in hematopoiesis has not been reported. Zyxin proteins may regulate gene transcription by interaction with transcription factors.
According to the results of the biological significance analysis, the twenty top-ranked genes selected using the proposed algorithm are functionally important both for the process of hemopoietic cell differentiation and for the cancer pathogenesis. Most genes from the resultant gene subset are selected as biomarkers to recognize the leukaemia subtypes in several other studies [18] [19] [20] .
V. ESTIMATION OF THE ALGORITHM CONVERGENCE
To define the optimal prognostic value of each gene, it is necessary to estimate all the possible samples of m genes out of initial data matrix
computations and take the enormous computational resources. The heuristic approach to estimate the prognostic quality of genes used in the proposed algorithm allows assessing the gene prognostic values with a smaller number of iterations, using the repeated analysis of the randomly selected data samples with m M  genes from the initial matrix M N X  . Therefore, it is necessary to analyse the convergence of the proposed algorithm and its ability to receive the reliable estimation of the ranked prognostic values. For this purpose, we have analysed the variation of the rank vector for different number of iterations. As shown in Fig. 2 , for twenty genes at the top of the ranked list their rank order differs a lot after 20000 and 40000 iterations.
However, after approximately 200000 iterations the rank order of genes is stabilized without significant changes. Therefore, the proposed algorithm converges to near optimal solution and is able to perform the reliable gene ranking, using a relatively small number of iterations.
VI. CONCLUSION
The proposed algorithm allows selecting the most informative genes by ranking, where the stability of the ranks of individual genes is ensured by estimation of multiple samples from an initial data matrix. Such an approach helps to avoid overfitting and enables the unbiased estimate of the vector of ranks. At each iteration, the classification model constructed on the randomly generated training sample is verified on the test sample. The classification accuracy is the indicator of the prognostic ability of the individual genes. After the successful classification, the ranks of the participating genes become higher, meanwhile the search for the optimal ranking is performed not for each individual gene, but for the whole combination. The output matrix is modified after the pre-determined number of iterations, registering both the prognostic ability and the ranks of the individual genes. The stability of the rank vector serves as an optimality criterion and is estimated by computing Spearman correlation coefficient between the current and previous rank order. The proposed algorithm has been tested on the leukaemia dataset and its convergence is analysed considering the twenty top-ranked genes. The analysis of the biological significance of the investigated gene subset allows confirming its obvious functional relevance to the phenotype it predicts and the processes taking place in the leukemic cells. It assures that the top-ranked genes are highly unlikely to be selected by chance. The comparative analysis of the developed algorithm on the leukaemia dataset shows its advantage over analogues, notably the selected set of biomarkers is smaller, consisting of four genes, which provide similar or higher classification accuracy. Currently she is a Senior Researcher at the Department of Bioinformatics, United Institute of Informatics Problems (UIIP), National Academy of Sciences of Belarus (NASB), Minsk, Belarus. At the beginning of her career she was engaged in mathematical modelling of different engineering processes. Since 2003 she is strongly interested in statistical and intelligent data analysis in relation to medical data. Her main research interests include data mining methods, notably the neural network, genetic algorithms and fuzzy systems and their application to analysis of medical and biological data. She has published more than 30 papers in peer-reviewed journals and conference proceedings.
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Contact information: Department of Bioinformatics, United Institute of Informatics Problems, 6 Surganova Str., Minsk, 220012, Belarus. Phone: +375-17-2842092, e-mail: novosel@newman.bas-net.by Natalija Novoselova, Igors Toms, Arkādijs Borisovs, Inese Poļaka. Īpašību ranžēšana, izmantojot daudzējādu datu kopu klasifikācijas precizitātes vērtējumu Rakstā izskatīts gēnu ranžēšanas algoritms, kuru var izmantot ar datiem, kas iegūti no mikročipu tehnoloģijas pielietošanas. Piedāvātais algoritms ļauj noteikt informatīvākos gēnus gēnu ekspresijas datos, turklāt atsevišķu gēnu rangu nozīmes stabilitāti garantē vairākkārtējs novērtējums datu kopās, kas iegūtas no sākotnējās datu kopas. Tas ļauj izvairīties no pārapmācības un nerada nobīdes rangu vektora atzīmēs. Atbilstoši algoritmam, katrā iterācijā klasifikācija tiek veikta apmācības datu kopā, kura gadījuma veidā izveidota no sākotnējās datu kopas, kā arī tiek veikta klasifikācijas modeļa verifikācija, izmantojot testa datu kopu. Klasifikācijas precizitāte ir mērs, pēc kura novērtē atlasīto gēnu prognostiskās īpašības. Katrā nākamajā algoritma iterācijā rangs gēniem, kas piedalījās veiksmīgā klasifikācijā, tiek paaugstināts, turklāt optimālā aranžējuma meklēšana notiek nevis katram gēnam atsevišķi, bet gan visai atlasītajai kombinācijai. Izejas matrica tiek modificēta pēc noteikta iterāciju skaita izpildīšanas, fiksējot gan tās prognostiskās spējas, gan atsevišķu gēnu rangu. Rangu vektora optimalitātes kritērijs ir tā vērtību stabilizācija, kuru novērtē, izmantojot Spīrmena korelācijas koeficientu. Piedāvātais algoritms ir notestēts, izmantojot leikēmijas datu kopu, un ir veikta algoritma saderības novērtēšana, izmantojot 20 gēnus, kas atrodas ranžētā saraksta augšpusē. Tika novērtēta apskatītās atlasīto gēnu apakškopas bioloģiskā nozīme, kas ļauj izdarīt secinājumus par to ciešo saistību ar procesiem, kas notiek leikēmijas šūnās. Šādā veidā var secināt, ka atlasītie gēni ar augstāko ranga vietu nav izvēlēti nejauši. Salīdzinošā analīze ar citu autoru darbiem, kas īstenoti, izmantojot šo pašu datu kopu, uzrādīja piedāvātā algoritma priekšrocību, jo, izmantojot to, tika atlasīta vismazākā biomarķieru kopa, kas saturēja četrus gēnus un nodrošināja līdzvērtīgu vai labāku klasifikācijas precizitāti.
Наталья Новоселова, Игорь Том, Аркадий Борисов, Инесе Поляка. Ранжирование признаков для обнаружения биомаркеров в данных генной экспрессии В статье рассматривается алгоритм ранжирования генов, полученных с использованием технологии микрочипов. Предложенный алгоритм позволяет выделять наиболее информативные гены в данных генной экспрессии, причем стабильность значений рангов отдельных генов обусловлена многократной оценкой выборок из исходной матрицы данных, что помогает избежать переобучения и способствует получению несмещенных оценок вектора рангов. Согласно алгоритму, на каждой итерации выполняется классификация случайным образом сформированной обучающей выборки с верификацией классификационной модели на тестовой выборке. Точность классификации является показателем прогностической способности отобранных генов. На каждой последующей итерации алгоритма ранг генов, участвующих в успешной классификации повышается, при этом поиск оптимального ранжирования осуществляется не для каждого гена в отдельности, а для всей отобранной комбинации. Выходная матрица модифицируется после выполнения заданного количества итераций, фиксируя как прогностическую способность, так и ранг отдельных генов. Критерием оптимальности вектора рангов является стабилизация его значений, что оценивается с использованием критерия корреляции Спирмена. Предложенный алгоритм протестирован на наборе данных по лейкемии, и проведена оценка сходимости алгоритма на примере 20 генов, расположенных вверху ранжированного списка. Оценена биологическая значимость исследуемого подмножества отобранных генов, которая позволяет сделать вывод об их тесной связи с процессами, происходящими в лейкемических клетках. Таким образом, отобранные гены с наивысшим рангом не являются результатом случайного отбора. Сравнительный анализ с работами других авторов по исследуемому набору данных показал преимущество предложенного нами алгоритма, так как после его применения было отобрано наименьшее подмножество из четырех биомаркеров, обеспечивающих схожую или лучшую точность классификации.
